Cornerstone Research Staff and Affiliated Experts Submit Comments on the Joint FTC-DOJ Draft Merger Guidelines
The Federal Trade Commission and the Department of Justice’s Antitrust Division launched a joint public inquiry to solicit comments from the public on the draft updated merger guidelines.
11th Bill Kovacic Antitrust Salon
Bob Majure will participate in a panel titled, “At Last, the Ultimate Merger Guidelines?” at this annual thought leadership event.
EC Investigation into Cloud Technology Company Merger
The European Commission cleared this merger after an investigation.
Amgen Inc.’s Acquisition of Horizon Therapeutics plc
The FTC approves Amgen’s $28B purchase of Horizon.
Antitrust Economics at a Time of Upheaval: Recent Competition Policy Cases on Two Continents
Cornerstone Research professionals and affiliated expert contributed chapters on recent mergers.
Recent Advances in Economic Methodology for Coordinated Effects
This Antitrust Chronicle article discusses methodologies for reviewing coordinated effects.
In re HIV Antitrust Litigation
The jury found in favor of the defense concluding, consistent with Dr. Saravia’s testimony, that the settlement contained no payment for delay.
Accounting for the Employee-Employer Relationship in Antitrust Analysis
The authors discuss how failing to account for the incentives and benefits that arise within long-term employee-employer relationships can lead to incomplete and incorrect economic analysis.
Canadian Pacific Railway/Kansas City Southern
The Surface Transportation Board approved the $31 billion acquisition of Kansas City Southern by Canadian Pacific Railway.
Recent CAT judgments yield lessons on the collection and submission of economic evidence
The authors provide an economist’s perspective on recent decisions from the Competition Appeal Tribunal.
GCR Live: Law Leaders Europe 2023
Vikram Kumar will discuss issues related to divergence and fragmentation in global antitrust at this annual conference in Brussels.
United States et al. v. UnitedHealth Group Incorporated et al.
Professors Gowrisankaran and Handel testified at trial regarding this proposed $13.8 billion healthcare industry merger.
How can we help you?
If you are looking for a publication not on our website, contact us.